Brief: Bajaj Healthcare Gets License From DRDO To Make '2-Deoxy-D-Glucose'
07/07/2021 12:55
July 7 (Reuters) - Bajaj Healthcare Ltd BAJH.BO :
* BAJAJ HEALTHCARE - GETS LICENSE FROM DEFENCE RESEARCH AND
DEVELOPMENT ORGANISATION TO MANUFACTURE AND MARKET
'2-DEOXY-D-GLUCOSE
* BAJAJ HEALTHCARE - GETS LICENSE FROM DRDO TO MAKE
'2-DEOXY-D-GLUCOSE' (2-DG), USED IN CONTROL & TREATMENT OF
COVID-19
Source text for Eikon: ID:nBSE53b1f5
Further company coverage: BAJH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bajaj Healthcare
See all newsIndia's Bajaj Healthcare falls on agreement to sell Gujarat undertaking for $1.5 million
Brief: Bajaj Healthcare June-Quarter Profit 137 Million Rupees
Brief: Bajaj Healthcare's Board Approves Sale Of Operational Business Unit At Tarapur
Brief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees